IchorLabs is a biotechnology company with the primary focus to improve current non-invasive diagnostic tests in the areas of oncology, prenatal diagnostics, and infectious diseases. We offer an innovative technology which features high-yield separation of all genetic biomarkers from body fluids for supporting liquid biopsy testing with high detection sensitivity. Large quantities of biomarkers accumulated using our technology could allow accurate early cancer diagnosis. We are looking for partners for further technology and product development in forms of: - Licensing and assignment deals - Venture capital investments